AROSIO, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 18.736
EU - Europa 8.632
AS - Asia 8.607
SA - Sud America 1.897
Continente sconosciuto - Info sul continente non disponibili 532
AF - Africa 195
OC - Oceania 70
Totale 38.669
Nazione #
US - Stati Uniti d'America 18.422
CN - Cina 3.240
SG - Singapore 2.536
UA - Ucraina 1.891
DE - Germania 1.857
PL - Polonia 1.657
BR - Brasile 1.575
HK - Hong Kong 863
VN - Vietnam 683
IT - Italia 614
FI - Finlandia 608
RU - Federazione Russa 476
GB - Regno Unito 463
FR - Francia 364
IN - India 346
TR - Turchia 308
IE - Irlanda 305
BD - Bangladesh 181
CA - Canada 159
SE - Svezia 120
AR - Argentina 109
ID - Indonesia 85
MX - Messico 72
IQ - Iraq 69
AU - Australia 66
ZA - Sudafrica 60
EC - Ecuador 59
JP - Giappone 49
ES - Italia 43
VE - Venezuela 43
NL - Olanda 41
NG - Nigeria 39
CH - Svizzera 36
CO - Colombia 32
BE - Belgio 30
PK - Pakistan 27
CZ - Repubblica Ceca 26
PY - Paraguay 25
IR - Iran 23
SA - Arabia Saudita 23
UZ - Uzbekistan 21
KE - Kenya 18
PE - Perù 18
CL - Cile 17
JM - Giamaica 17
AT - Austria 16
MA - Marocco 16
EU - Europa 15
KR - Corea 15
LT - Lituania 15
EG - Egitto 14
SC - Seychelles 14
TN - Tunisia 13
JO - Giordania 12
NP - Nepal 12
PH - Filippine 12
AE - Emirati Arabi Uniti 11
CR - Costa Rica 11
IL - Israele 11
KZ - Kazakistan 11
UY - Uruguay 11
DO - Repubblica Dominicana 10
AL - Albania 9
HN - Honduras 9
RO - Romania 9
AZ - Azerbaigian 8
GT - Guatemala 8
BO - Bolivia 7
BG - Bulgaria 6
MY - Malesia 6
PA - Panama 6
PT - Portogallo 6
BB - Barbados 5
BY - Bielorussia 5
DZ - Algeria 5
HU - Ungheria 5
LK - Sri Lanka 5
OM - Oman 5
SY - Repubblica araba siriana 5
AM - Armenia 4
HR - Croazia 4
KG - Kirghizistan 4
LB - Libano 4
LV - Lettonia 4
MU - Mauritius 4
NI - Nicaragua 4
PS - Palestinian Territory 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GE - Georgia 3
GR - Grecia 3
KW - Kuwait 3
MD - Moldavia 3
ML - Mali 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
RS - Serbia 3
TH - Thailandia 3
Totale 38.117
Città #
Fairfield 2.250
Woodbridge 2.147
Warsaw 1.651
Ashburn 1.539
Houston 1.418
Jacksonville 1.374
Singapore 1.335
Cambridge 909
Seattle 902
Ann Arbor 898
Hong Kong 856
Wilmington 808
Princeton 561
Nanjing 519
The Dalles 515
Beijing 494
San Jose 489
Chandler 369
Helsinki 310
Dublin 303
Los Angeles 272
Columbus 249
Istanbul 248
Lauterbourg 241
New York 227
Ho Chi Minh City 213
Nanchang 212
Brescia 185
Dearborn 182
Shenyang 150
São Paulo 138
San Diego 135
Buffalo 134
Hanoi 127
Changsha 117
Des Moines 114
Moscow 111
Milan 99
Jiaxing 98
Hebei 97
Dallas 96
Tianjin 96
Council Bluffs 87
Munich 87
San Francisco 83
Jinan 82
Dong Ket 76
Kunming 71
Shanghai 71
Chicago 63
Santa Clara 60
Orem 58
Melbourne 54
Redondo Beach 54
Hangzhou 53
Toronto 52
Verona 52
Rio de Janeiro 49
Zhengzhou 41
Jakarta 40
Ningbo 40
Abuja 38
Phoenix 38
Tokyo 38
Brasília 37
London 34
Nürnberg 34
Brooklyn 33
Guangzhou 33
Taizhou 33
Curitiba 32
Frankfurt am Main 32
Turku 32
Chennai 30
Haiphong 30
Johannesburg 30
Brussels 29
Lanzhou 28
Atlanta 26
Montreal 26
Baghdad 24
Boston 24
San Mateo 24
Belo Horizonte 23
Denver 23
Mexico City 23
Da Nang 22
Monmouth Junction 22
Stockholm 22
Taiyuan 22
Leawood 21
Mumbai 21
Campinas 20
Changchun 20
Croydon 20
Kocaeli 20
Poplar 20
Amsterdam 19
Haikou 19
Norwalk 19
Totale 25.402
Nome #
Mitochondrial ferritin deficiency reduces male fertility in mice 351
Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity 343
Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. 331
Heparanase overexpression reduces hepcidin expression, affects iron homeostasis and alters the response to inflammation 331
Hepcidin antagonists for potential treatments of disorders with hepcidin excess 328
Iron homeostasis in health and disease 311
Behavioral characterization of mouse models of neuroferritinopathy 298
Biology of ferritin in mammals: an update on iron storage, oxidative damage and neurodegeneration 291
Photoacoustic molecular imaging for in vivo liver iron quantitation 276
Novel Functional Changes during Podocyte Differentiation: Increase of Oxidative Resistance and H-Ferritin Expression 267
Iron acquisition in Bacillus cereus: the roles of IlsA and bacillibactin in exogenous ferritin iron mobilization 259
The importance of eukaryotic ferritins in iron handling and cytoprotection 259
Ferritin exhibits Michaelis-Menten behavior with oxygen but not with iron during iron oxidation and core mineralization 256
Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells 246
The importance of iron in pathophysiologic conditions 232
Energetics of surface confined ferritin during iron loading 211
GLICOSAMINOGLICANI SOLFORATI, INCLUDENTI L'EPARINA, L'EPARINA A BASSO PESO MOLECOLARE E I LORO DERIVATI, PERL'IMPIEGO NEL TRATTAMENTO TERAPEUTICO DI ANEMIE E PER L'INIBIZIONE DELL'ESPRESSIONE DI EPCIDINA 208
A mutational analysis of the epitopes of recombinant human H-ferritin 208
High sulfation and a high molecular weight are important for anti-hepcidin activity of heparin 204
Identification of New Mutations of the HFE, Hepcidin, and Transferrin Receptor 2 Genes by Denaturing HPLC Analysis of Individuals with Biochemical Indications of Iron Overload. 200
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells 198
Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders. 196
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo 194
Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo 194
Development of a monoclonal antibody against human heart ferritin and its application in an immunoradiometric assay 186
Analysis of ferritins in lymphoblastoid cells lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome. 182
Chemico-physical and functional differences between H and L chains of human ferritin 181
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 180
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 180
A human mitochondrial ferritin encoded by an intronless gene 179
Erastin is a strong inducer of ferroptosis in human rhabdomyosarcoma cell lines 179
A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains 173
Ferritin, cellular iron storage and regulation 172
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo. 172
Characterization of human ferritin H chain synthetized in a Escherichia coli 171
Iron release from ferritin by flavin nucleotides. 171
Serum ferritin evaluation with radioimmunoassays specific for HeLa and liver ferritin types 170
Recombinant overexpression of camel hepcidin cDNA in Pichia pastoris: Purification and characterization of the polyHis-tagged peptide HepcD-His 169
Non-anticoagulant heparins are hepcidin antagonists for the treatment of anemia 168
Transient over-expression of human H and L ferritin chains in COS cells 166
Functional and immunological analysis of recombinant mouse H- and L-ferritins from Escherichia coli. 166
Use of a reference standard to improve the accuracy and precision of seven kits for determination of ferritin in serum 166
Production and characterization of functional recombinant hybrid heteropolymers of camel hepcidin and human ferritin H and L chains 166
Study of ferritin self-assembly and heteropolymer formation by the use of Fluorescence Resonance Energy Transfer (FRET) technology 166
A mutational analysis of the epitopes of the recombinant human H-ferritin 165
Structural and functional studies of human ferritin H and L chains 165
Expression and characterization of the ferritin binding domain of Nuclear Receptor Coactivator-4 (NCOA4) 164
Approaches for repressing frataxin in HeLa cells using small interfering RNAs. 163
Ferritins: A family of molecules for iron storage, antioxidation and more 162
Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation 161
The Ferritin-Heavy-Polypeptide-Like-17 (FTHL17) gene encodes a ferritin with low stability and no ferroxidase activity and with a partial nuclear localization 160
Facilitated diffusion of iron(II) and dioxygen substrates into human H-chain ferritin. A fluorescence and absorbance study employing the ferroxidase center substitution Y34W. 159
Analysis of the hepcidin mutant R59G, which causes an adult-onset type of hemochromatosis 159
Chemically and Biologically Harmless versus Harmful Ferritin/Copper-Metallothionein Couples 158
Defining metal ion inhibitor interactions with recombinant human H- and L-chain ferritins and site-directed variants: an isothermal titration calorimetry study 158
The sedimentation properties of ferritins. New insights and analysis of methods of nanoparticle preparation. 158
Immunological reactivity of serum ferritin in patients with malignancy 158
New signaling pathways for hepcidin regulation. 158
A novel deletion of the L-ferritin iron-responsive element responsible for severe hereditary hyperferritinaemia-cataract syndrome 157
Iron Oxidation and Core Formation in Recombinant Heteropolymeric Human Ferritins 156
Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice 156
BMP6 binding to heparin and heparan sulfate is mediated by N-terminal and C-terminal clustered basic residues 156
ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control. 155
An ELISA for the H-subunit of human ferritin which employs a combination of rabbit poly- and mice monoclonal antibodies and an enzyme labeled anti-mouse-IgG 155
Methodological effects on the quantitation of serum ferritin by radio- and enzymoimmunoassays 155
Characterization and expression of human and mouse mithocondrial ferritins 155
Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin 154
The heavy subunit of ferritin stimulates NLRP3 inflammasomes in hepatic stellate cells through ICAM-1 to drive hepatic inflammation 153
Analysis of ferritin genes in Parkinson disease. 153
The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin. 153
Use of a monoclonal antibody against human heart ferritin for evaluating acidic ferritin concentration in human serum 153
Approaches for repressing frataxin in HeLa cells using small interfering RNAs (siRNAs) 153
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation. 151
Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis 151
Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. 150
Reaction paths of iron oxidation and hydrolysis in horse spleen and recombinant human ferritins 150
Evidence that residues exposed on the three-fold channels have active roles in the mechanism of ferritin iron incorporation 149
Characterization of mice expressing the pathogenic L ferritin mutant (FTL-498insTC) causing hereditary Ferritinopathy 147
NCOA4-mediated ferritinophagy promotes ferroptosis induced by erastin, but not by RSL3 in HeLa cells 147
Macrophage and epithelial cell H-ferritin expression regulates renal inflammation 146
RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. 146
Ferroportin gene silencing induces iron retention and enhances ferritin synthesis in human macrophages 145
The ferritins: molecular properties, iron storage function and cellular regulation 145
Human ferritin H-chains can be obtained in non-assembled stable forms which have ferroxidase activity 145
Blotting analysis of native IRP1: a novel approach to distinguish the different forms of IRP1 in cells and tissues. 144
The putative "Nucleation Site" in human h-chain ferritin is not required for mineralization of the iron core 144
Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies 143
Multiple subunits in human ferritins: evidence for hybrid molecules 143
Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. 142
Characterization of serum ferritin in iron overload: possible identity to natural apoferritin 142
Ferritin in the red cells of normal subjects and patients with iron deficiency and iron overload 142
DHPLC scan of iron genes in consecutive patients with suspected iron overload 142
Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder 141
Approaches for repressing frataxin in HeLa cells using small interfering RNAs (siRNAs) 141
Immunohistochemistry of HFE in the duodenum of C282Y homozygotes with antisera for recombinant HFE protein 140
Structure, function, and evolution of ferritins 140
HEPARIN BINDING DOMAINS IN BMP6: STUDY ON THE SYNTHETIC PEPTIDES AND THE RECOMBINANT PROTEIN 140
Ferrous Ion Binding to Recombinant Human H-Chain Ferritin. An Isothermal Titration Calorimetry Study. 138
Mechanisms of regulation of ferritin synthesis in rat liver during experimental inflammation 138
Evidence that the specificity of iron incorporation into homopolymers of human ferritin L- and H-chains is conferred by the nucleation and ferroxidase centres 138
Totale 18.097
Categoria #
all - tutte 159.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.954 0 313 28 78 33 182 98 142 118 303 193 466
2022/20231.390 310 35 50 60 88 454 3 113 169 23 37 48
2023/20241.486 73 31 127 95 45 134 44 45 540 36 35 281
2024/20253.828 31 14 5 447 560 391 317 94 309 204 799 657
2025/20269.050 775 1.381 805 1.630 754 515 1.172 320 493 743 308 154
2026/2027673 528 145 0 0 0 0 0 0 0 0 0 0
Totale 38.669